Preliminary Ratings Assigned to Deutsche Bank's Sovereign Obligations Securitization Jul 01

  • ID: 2031449
  • July 2001
  • Standard & Poors
1 of 3

LONDON (Standard & Poor's CreditWire) July 10, 2001--Standard & Poor's today assigned its preliminary ratings to the €29.9 million floating-rate notes due July 2006 to be issued by Deutsche Bank AG (AA/Stable/A-1+) under its Repon 17 securitization (see list below). The repayment of the class A, B, and C notes is an obligation of Deutsche Bank AG and is linked to the performance of a €175 million static reference portfolio of emerging market sovereign reference entities. The preliminary ratings reflect the credit support in the form of subordination provided by the first loss piece, the credit risk of the reference portfolio, the review of the mechanics of the credit default swap, and the rating of an existing European medium-term note...

Companies mentioned in this report are:
- Deutsche Bank AG

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Deutsche Bank AG

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.